Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

How COVID-19 Vaccines Will Get From the Factory to Your Community

Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva
Australia Will Have Its Own Centre for Disease Control, Labor Party Vows

Harvard Wyss Institute Licenses Diagnostic Technologies to Agile Biodetection

by Global Biodefense Staff October 8, 2020, 7:36 am
How Pharma is Changing to Produce a Pandemic Vaccine in Rapid Time

by Beatrice Melinek and Stephen Morris October 5, 2020, 10:44 am
The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic

by Anna Nagurney October 5, 2020, 9:32 am
Pandemic Testing Capacity: 3D Printed Nasal Swabs Shown Comparable to Flocked Swabs

by Global Biodefense Staff September 25, 2020, 9:26 am
The Challenge of Vaccine Cold Chain Logistics: How a Chemical ‘Casing’ Could Save Lives

by Asel Sartbaeva and Aswin Doekhie, University of Bath September 4, 2020, 12:15 pm
UCLA Study Backs Decontamination of Single-Use N95 Respirators to Mitigate Shortages

by Global Biodefense Staff August 27, 2020, 3:25 pm
Vaccine Approval Is Just The Beginning – Huge Production Challenges Await

by Bruce Y. Lee, CUNY August 24, 2020, 6:48 am
NDAA Amendment Proposes Further Scale Up of PPE and Diagnostic Supplies

by Global Biodefense Staff June 30, 2020, 1:45 pm
The Next Once-a-century Pandemic is Coming Sooner Than You Think – But COVID-19 Can Help Us Get Ready

by David Murdoch, University of Otago June 14, 2020, 11:06 am
AstraZeneca Teams with Oxford Biomedica to Shore Up COVID-19 Vaccine Manufacturing Capacity

by Global Biodefense Staff May 28, 2020, 9:03 am
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
GSK Announces Plans to Produce 1 Billion Doses of Pandemic Vaccine Adjuvant in 2021

by Global Biodefense Staff May 28, 2020, 9:03 am
Vent Splitting Breakthrough Shows Promise During Global Ventilator Shortage

by Global Biodefense Staff May 23, 2020, 4:16 pm
CCDC Chemical Biological Center Strives to Become DoD’s Biomanufacturing Leader

by Global Biodefense Staff May 19, 2020, 4:00 pm
Hospitals Need Dialysis Equipment as Thousands of Coronavirus Patients Develop Kidney Problems

by Global Biodefense Staff April 19, 2020, 12:31 pm

Congratulations. You've reached the end of the internet.

Supply Chain

How COVID-19 Vaccines Will Get From the Factory to Your Community

Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire

U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva

Australia Will Have Its Own Centre for Disease Control, Labor Party Vows

Harvard Wyss Institute Licenses Diagnostic Technologies to Agile Biodetection

How Pharma is Changing to Produce a Pandemic Vaccine in Rapid Time

The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic

Pandemic Testing Capacity: 3D Printed Nasal Swabs Shown Comparable to Flocked Swabs

The Challenge of Vaccine Cold Chain Logistics: How a Chemical ‘Casing’ Could Save Lives

UCLA Study Backs Decontamination of Single-Use N95 Respirators to Mitigate Shortages

Vaccine Approval Is Just The Beginning – Huge Production Challenges Await

NDAA Amendment Proposes Further Scale Up of PPE and Diagnostic Supplies

The Next Once-a-century Pandemic is Coming Sooner Than You Think – But COVID-19 Can Help Us Get Ready

AstraZeneca Teams with Oxford Biomedica to Shore Up COVID-19 Vaccine Manufacturing Capacity

GSK Announces Plans to Produce 1 Billion Doses of Pandemic Vaccine Adjuvant in 2021

Vent Splitting Breakthrough Shows Promise During Global Ventilator Shortage

CCDC Chemical Biological Center Strives to Become DoD’s Biomanufacturing Leader

Hospitals Need Dialysis Equipment as Thousands of Coronavirus Patients Develop Kidney Problems

Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

Does SARS-COV-2 Launch a Direct Viral Attack on the Brain?

Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

What is the Spike Protein and Why Are Mutations On It Important?

Key Questions on New Variant of SARS-CoV-2 Answered by UK Genomics Researcher

Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research

Originally Built for Bioterrorism Agents, This Decontamination System Now Clears SARS-CoV-2 from Military Aircraft

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

State Department: Reducing Revisionist State Biological and Chemical Weapons Threats

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

W. Virginia CBRN Response Enterprise Assists with COVID-19 Testing Innovation Roll Out

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles